Winton Group’s Biohaven BHVN Stock Holding History

Winton Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-64,028	Closed	-$723K	–	1124
2025 Q4	$723K	Buy	64,028 +36,929	+136%	+$458K	0.03%	556
2025 Q3	$407K	Buy	+27,099	New	+$394K	0.02%	595

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winton Group's BHVN Position: Q1 2026 in Review

Winton Group sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 64,028 shares — an estimated $723K sold.

Winton Group first reported a position in BHVN in Q3 2025 and held it in 2 quarters. The position peaked at $723K in Q4 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Winton Group reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Winton Group sold 64,028 Biohaven shares in Q1 2026, an estimated $723K.
Winton Group first reported a position in Biohaven in Q3 2025 and held it in 2 quarters.
Winton Group's Biohaven position peaked at $723K in Q4 2025.
276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.